Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Ad Verheul

Ad Verheul

Centre De Hartenberg Netherlands Netherlands

Ahmed M lutfi Al

Ahmed M lutfi Al

Iman university of Baghdad Iraq Iraq

Ahmet Turan ISIK

Ahmet Turan ISIK

Dokuz Eylul University Turkey Turkey

Alan M. Palmer

Alan M. Palmer

Cerebro science Ltd UK UK

Ali H Alwadei

Ali H Alwadei

National Neuroscience institue saudi arabia Saudi Arabia

Amos Korczyn

Amos Korczyn

Tel Aviv Universtiy Israel Israel

Amri Tamiz

Amri Tamiz

Nantional Institue of Health USA USA

Ana Patricia Aguilera Hermida

Ana Patricia Aguilera Hermida

Penn State university USA USA

Parkinsons Congress 2019

About Conference


ConferenceSeries  proudly presents 5th World Congress on Parkinsons & Huntingtons Disease We invite participants around the world to Vienna, Austria for Parkinsons Congress 2019 held during August 29-31,2019.

Parkinsons Congress deals with Neruological Syndromes caused due to leakage of electric impulse in neurons which leads to loss of communication. This kind of medical conditions are getting frequent in humans at present situations. It has been observed there are number of diseases associated with Neurological disorders for examples Parkinsons diseases, Huntingtons disease, Alzheimer’s disease, brain tumors, Multiple Sclerosis, Spinal Muscualr Atrophy, Brain Stroke, Epilepsy, Amyotrophic Lateral Sclerosis

According to current survey Neurological disorders occupy first place in Europe Brain disorders are like Brain Tumor, Cerebral palsy, chiari malformation, Craniofacial abnormalities, Craniosynostosis, Developmental disorders, Encephalopathy, Epilepsy etc are recognized by World Health Organization in Europe. It is been identified 1.2 million people in Europe are suffering with Parkinsons approximately 260000 people in Germany, 200000 people in Italy, 150000 people in Spain, 120000 people in UK, 117000 people in France are suffering from Parkinsons disease.

World Health Organization(WHO) and World Federation of Neruology (WFN) were collaborated after find the rate of Neurological disorders world wide. An international Survey of Country Resources for Neurological disorders effects 109 countries and covering over 90% of the world’s population. This survey help to collect valuable information regarding aspects of neurological care all around the world  

 At National Institute of Health funding package is of $34 billion for the economic year 2017 to improve life of patients who are suffering from Parkinson’s disease and to rise the awareness on Neurological disorders around the World. PRP (Parkinson's Research Program) fund received amount of $16 million annually to research in Neuromuscular disorders such as Alzheimer’s, Parkinson’s disease, Huntington’s disease.

ConferenceSerise Organize 3000 conference yearly around the World and gather eminent persons  with an idea of Ameliorating Human life

Why to attend?

5th World Congress on Parkinsons & Huntington Disease provides best plat form for Neruologists, Neurosurgeons, Scientists, Clinical Industry Specialists, Neruology Experts, Young Researchers with an aim to make patients feel better with innovative research outcomes

Target audience:

Neuro physicians, Neruo surgeons, Neurologists, Psychiatrist, Physiotherapists, Neruo Specialists, Researchers, Professors, Industrials Experts, Nutritional Scientists, Lecturers and Students from Academic study in Prkinsons and Huntingtons diseases , Pharma researchers on Neurology and Neuroscience, Therapists and Diagnostic Experts 

 

Market Analysis

On behalf of our Organizing committee members we welcome attendees like Speakers, Exhibitors, delegates, Poster presenters, Students, Young researchers from across the world to unleash the innovative ideas in the field of neuroscience and brain disorders at Parkinsons congress 2019 held during 29-31, August 2019

This Parkinsons International conference of Europe focus on innovative ideas of Parkinsons and Huntington diseases treatment and research  

Reasons to undertake:

Parkinsons congress receive great response and support from worldwide Neuro Researchers. As  previous Parkinsons conferences  we aspire to make Parkinsons congress 2019 a grand success with the support of highly eminent speakers from Neuro science and Parkinson’s disease communities. We promise our speakers world class hotel facilities and hospitality along with updated research knowledge on Parkinsons and other neurological disorders.

According to World Health Organization (WHO) and World Federation of Neurology survey 6.3 million people are suffering with Parkinsons disease. The age is usually over 60 but it is estimated that one in tem are diagnosed before the age of 50 and it can affect people in their 40’s and younger Especially in Europe Parkinson’s disease is diagnosed 1 per 1000 people making it second most common neurodegenerative disorder.

As per the Neurological research till date with was clear that Dopmaine a neuro transmitter in brain gradually fall its level. Which leads to Parkinson’s disease it was observed that Dopamine – generating cells known as dopaminergic neruons in the substantia nigra part of brain have died. Research say a male has 50% higher risk of developing Parkinson’s disease than a female, This progressive nervous system disorder affects the persons movement like speak, write and other voluntary movements different treatments for Parkinson’s disease were used but still death rate of Parkinson’s disease was gradually increasing. Approximately one million adults in USA are living with Parkinson’s disease and 60000 are diagnosed yearly and In United Kingdom 127000 people have Parkinson’s disease

About Vienna:

This convocation can target the recent advances and novel ideas in every series of Parkinson’s analysis, and it'll supply an unrivalled occasion for specialists from everywhere the world to satisfy, collaborate, and disengage with numerous scientific relations.

Vienna is that the capital town of Oesterreich, Vienna is additionally delineated as Europe's cultural capital, a metropolis with distinctive charm, plangency and aptitude. Vienna may be a town with a awfully prime quality of life, a feature that's extremely appreciated by the various guests WHO come back to the Austrian capital. town is in jap a part of Oesterreich just about Czech Republic, Slovak Republic and Republic of Hungary. The Vienna traveler Board provides comprehensive info regarding sights, hotels and leisure activities in Vienna to relinquish guests a structured summary of the various events and attractions within the town. The inflow of visitors|of travelers|of holiday makers} from everywhere the planet has created Vienna Austrian capital of Oesterreich national capital the foremost standard urban tourist destination in Austria. Vienna is understood for its prime quality of life. Vienna, a town of music, town of art, town of culture, possesses a full of life and large array of cultural attractions. This town may be a dream city for any one with a romantic streak or an interest in history. rubber-necking opportunities are to be found in abundance. Austria's climate is additionally moderate and gentle and dependably follows the four distinct seasons. Average summer temperatures vary from 20°C to 30°C; the typical winter temperatures are around 0°.

Focused concepts in congress:

Parkinson’s disease

Neuroscience

Neuromuscular Disorders

Environment and genetic changes involvement in neuro transmitters

Effect of free radicles and aging in patients

Diagnosis and imaging of Parkinson’s disease

Pathophysiology and neuropsychiatry

Neurogenic Orthostatic Hypotension

Parkinson’s disease condition.

Medication and surgery for Parkinson’s disease

Major Associations around the globe:

National Parkinson Foundation

American Parkinson Disease Association (APDA)

Parkinson’s disease Foundation

Movement Disorder Society of Australia

Parkinson's Unity Walk

Movement Disorder Society of Japan

Moroccan Neurological Society Movement Disorders Group

Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia

Ecuador Movement Disorders Group

Austrian Parkinson's Disease Society

Danish Movement Disorder Society

International Parkinson and Movement Disorder Society

Parkinson’s Disease and Movement Disorders Society of India

Top universities globally working in the field of Parkinson Disease

University of Bath

The University of Queensland

University of Bristol

University of Cambridge

The Imperial College of Science and Medicine

Duke University

University of Milan

Karolinska Institute

University of Hamburg

The University of Edinburgh

University of Munich

University of Rochester

University of Zurich

Leiden University

University of Bristol

University of Helsinki

University of Freiburg

University of Frankfurt

Top universities in Austria:

Medical University of Vienna

Medical University of Innsbruck

Medical University of Graz

University of Vienna

Paracelsus Private Medical University

 

Past Conference Report

On behalf of Organizing Committee, we take an immense pleasure in announcing the inauguration of 4th World Conference on Parkinson’s and Huntington Disease -2018 during August 29-30,2018 at Zurich, Switzerland. We have received a benevolent response around the globe for Parkinsons Congress 2018. The conference was conducted with the theme “Scientific Innovations & Research Ideologies in Parkinsons and Huntington Diseases”. This conference was noticeable with the presence of eminent researchers with their novel ideas, business delegates and talented young research communities.

This conference created a platform to meet Leading World Parkinsons doctors, Neurosurgeons, Neuro radiologists, Clinicians, Deans, Care Experts, Scholars and other professionals in which many topics were discussed in depth to provide up-to-date information to the world regarding Parkinson’s disease. While, the summit ended up in providing an occasion to share concepts and practices.

The platform was decorated with peerless speakers, who enlightened the delegates with their novel research ideas and on various scientific topics related to the field of Parkinson’s disease. The eminent personalities at the conference were Chandramohan Wakade, Augusta University, USA, R C Hider King’s College London, UK, Jae Moon Lee, Kainos Medicine Inc., South Korea, Byung-Jun Park.

We take opportunity to appreciate to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Associates and Editorial Board Members of Journal of Neurological Disorders, Journal of Alzheimer Disease & Parkinsonism, Journal of Neurology & Neurophysiology and who supported the conference in every aspect for making an enormous success.

We once again thank all the communities of research for long term support and massive positive response. This encourages us to continue organizing events and conferences for advancing the Research in helping human life. Therefore, it is glad to announce commencement of "5th World congress on Parkinsons and Huntington Disease" which will be held during August 29-31, 2019 Vienna, Austria.

About Venue

About city

Vienna is Associate in Nursing Austrian state. it's the capital of the Republic of Austria Oesterreich European country European nation and by an extended shot the most important town in Austria with its population of in way over one.7 million.  Austria's social, monetary, and political focus. because the previous home of the dynasty court and its completely different domains, town still has the trimmings of the splendid capital it wont to be, and therefore the unforgettable downtown space is recorded on the UN agency World gift summation.

Vienna is one in all the wealthiest districts within the European Association: Its gross territorial results of EUR forty seven,200 for each capita established twenty five.7% of Austria's Gross domestic product in 2013. It adds up to 159% of the EU traditional. town increased its scenario from 2012 on the positioning of the foremost financially ground-breaking urban areas achieving variety 9 on the posting in 2015

the development and generation of wines within town fringes have a high socio-social esteem. the foremost essential business segments ar exchange (14.7% of enclosed Associate in Nursing incentive in Vienna), logical and mechanical administrations, land and lodging exercises and collection of merchandise. In 2012, Vienna's commitment in Austria's active and approaching remote direct ventures was of around , that shows Vienna's job as a universal centre purpose for family and outdoors organizations

The city of Austrian capital joins significance to science and appearance into and centres around creating a positive scenario for innovative work. In 2014, Austrian capital has duty-bound one,329 analysis offices; forty,400 individuals ar used within the analysis and development space and thirty fifth of Austria's analysis and development prices are place resources into town.

14.99 million Voyagers visited Austrian capital in 2016. In 2014, 6.2 million guests visited Austrian capital land amounted to thirteen,524,266 medium-term remains. The principle markets for travellers are European country, the Unified States, Italy and Russia. Somewhere within the vary of 2005 and 2013, Austrian capital was the world's main goal for worldwide congresses and traditions. In 2014, 202 international gatherings were control in Austrian capital, creating it the second most accepted congress space worldwide as indicated by the measurements of the Universal Congress and Tradition Affiliation. Its biggest meeting focus, the Republic of Austria Canter Austrian capital (ACV) has Associate in Nursing mixture limit with relevancy around twenty,000 people and is organized aboard the Assembled Countries Central command in Austrian capital completely different focuses are the Messe Wien Show and Congress centre (up to three,300 individuals) and therefore the Hof burg Royal residence (up to four,900 individuals).

 

 

Sessions

Session on: Parkinson Disease

Parkinson’s disease (PD) is a chronic and progressive disease of nervous system that possess symptoms which continue and become worse over time. It is the second commonest neurodegenerative disease after Alzheimer's disease, and in the UK, has a lifetime prevalence of between 0.1 and 0.3% of the population. The basic reason behind this condition is malfunction and death of vital nerve cells in brain. In normal conditions nerve cells present in the brain produces a neuro transmitter called dopamine that is responsible for signalling movement, emotions and co-ordination but in the case of diseased individual dopamine production slows down, hence the individual become unable to control the movement normally. There is no cure but treatment involves medication and surgery. Slowness of voluntary movements, reduced facial appearance, repetitious tongue, and diminished eye flashing, A shuffling gait with deprived arm swing and curved posture, Shaky stability; difficulty rising from a sitting position, Swallowing problems in later stages.

Related Parkinsons Conference | Parkinson congress | Parkinsons Disease Conference | Parkinsonism congress | Parkinson’s disease conference

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk,

Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on:  Epidemiology of Parkinsons

Parkinsons disease is a neurodegenerative disorder and the cause of it remained a mystery to the scientific community. Researchers says by exposing to harmful chemicals and Pesticides mutations occurs in the genes and results in neurological disorders. With age, the condition of disease increases exponentially and men are in higher proportion to prone compared to women. On an average 10million individuals are found to be suffering from Parkinson’s disease, from where only four percent of people with Parkinson’s disease are diagnosed before the age of 50. An estimated of 40% to 60% of Parkinson disease patients suffering from depression. United States stands in the fourth position in considering the death of people due to Parkinson’s disease.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

 

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary,  International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on:  Neuromuscular Disorders

Neurons are the specialized cells that are responsible for communication, when they cannot produce signals communication between nervous system breaks and results in neuromuscular disorders. Most of these disorders are thought be inheritable and treatment is given to improve the life of patient and no cure is available to completely eradicate the condition.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Huntington Disease

Huntington’s disease is inherited from Parents and often symptoms will be more like Parkinson’s disease which include problem with mood, mental abilities, Swallowing, Speaking, Sleep Disturbances followed by loss of co-ordination and unsteady gait. A gene called HTT(Huntingtin) which is responsible for coding protein Huntingtin, if any mutation to that gene it will cause disturbances in the brain and results in death of brain cell and leads to Huntington’s disease. Abnormalities with the mutant huntingtin include Cardiac Failure, Weight Loss, Osteoporosis, reduced glucose level. This condition is normally observed in the individuals under the age of fifties.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on: Risk Factors of Parkinson’s disease

Symptoms and progression of disease will not be similar among the suffering individuals but people with Parkinson’s are at higher rate of developing related risks. Developing these conditions is not a certainty, only a possibility. Knowing the conditions can help a person with Parkinson’s disease or associated symptoms and helps to take preventative measures for a better life. Parkinsons disease have a chance of creating mental ailment which can be mild or serious. It includes cognition (early stage symptoms), mood, behaviour which are considered as major impairment when compared to normal populational. The common mood alterations seen in the patients are despair, eagerness, indifference.

Related Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neuromuscular Conference

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Pathophysiology and Pharmacology

Parkinson’s disease is originated because of the gradual loss of cells in the substantia nigra of the brain. Dopamine is a neurotransmitter that transmits signals between two regions of the brain to coordinate activities like movement of limbs. If there is deficiency in dopamine production results in loss of co-ordination and end up with symptoms of Parkinson’s Disease. As the disease progresses, nervous system and brain degenerates causing a higher movement disorder.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on: Diagnosis for Parkinson’s disease

Early stage identification of Parkinson’s disease is difficult but includes some imaging studies. MRI (magnetic resonance imaging) and CT (computer tomogram) are used by many physicians to find out other relating Parkinson’s diseases such as encephalitis, Tumours, Hydrocephalus. Level of dopamine release and activity of brain can easily detect using PET and SPECT examining.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Parkinson’s disease: Complications

Parkinson's disease is usually accompanied by additional problems, which may be cured and they       are thinking difficulties, swallowing problems, depression and emotional changes, sleep difficulties, constipation, blood pressure changes, fatigue, pain.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Mitochondrial Dysfunction

The known cause of Parkinson’s disease is reduced level of dopamine production by neurons in the brain but surprisingly the main cause was malfunctioning of cell organelles like mitochondria leads to increased oxidative stress which in turn results in cell death and finally ends with Parkinsons disease with motor and non-motor symptoms. The reason may be both genetic and environment factors.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Insights and therapeutics: Parkinson’s disease

No cure has been identified to Parkinson’s disease, but use of drugs can slow down the progression. Normally prescribed by physicians include change of life style, regular aerobic exercise and prescribed therapeutic supplement. It is noted that people will have beneficial effect who are taking co-enzyme Q10 during their initial stage of disease. It is unclear how genetical changes cause Parkinson disease or influence the risk of developing the disorder. Some gene mutations(alterations) such as LRRK 2, PARK 7, PINK 1, PRKN disturb the cell mechanism that breaks down undesired proteins in neurons which are responsible for dopamine production. Hence, undegraded proteins accumulate, resulting in death of vital nerve cells and subsequently lowers the level of dopamine production. In most cases of Parkinson disease, protein deposits called Lewy bodies. It is unclear whether Lewy bodies play a key role in killing nerve cells or just part of the cells which are responsible to the disease. Yoga, massage, acupuncture, meditation, music or art therapy, alexander technique is also regarding as best methods to control neurological disorders particularly Parkinson’s disease, Alzheimer’s and neuropsychiatric. Tetrabenazine, neuroleptics, mirtazapine can be taken to for treating chorea.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary,  International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

.Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Managing life with Parkinson’s disease

Since the symptoms and progression of disease are not similar among individuals early stage detection can help to reduce the worseness. Treatment and complete abolition is not known to research groups but maintaining the instructions and following the medication prescribed by physician can better the life. Individual should get practised to maintain the stress levels and depression by daily communicating with close relatives, friends. Patients can improve the life by following guidelines given by counsellor.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association.  

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Neurosurgery

Presently Deep brain stimulation is widely recommended for improving people suffering with Parkinson’s disease one is deep brain stimulation (DBS) and is performed by inserting a tube in the small intestine and is used to treat a variety of deactivating neurological symptoms most commonly the draining symptoms of Parkinson’s disease (PD), such as tremor, rigidity, stiffness, slowed movement, and walking problems. There will be no effect with using DBS to healthy brain tissue by terminating nerve cells. Instead the procedure blocks electrical signals from targeted areas in the brain.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Free Radicles and Aging in Parkinsons

Free radicles have both beneficial and baleful effect to human body. These are produced with in the body by metabolism and enters body through external sources such as pollution, radiation, therapeutics etc; Oxidative stress is known to cause many neurological diseases such as Alzheimer’s, Parkinson’s disease, Amyotrophic lateral sclerosis(ALS). With oldness, there is a typical failure of the dopamine producing neurons. Out of surprise 2% of the 1 million people with the disease are thought to be below the age of fifty. In some of the rare situations symptoms are seen in children and teens and it is known as juvenile parkinsonism.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Novel Therapeutics

The commonly used drug to treat Parkinson’s disease is Levodopa which has higher frequency to develop motor Fluctuations and results in L-dopa-induced dyskinesia (LID). Since the Characteristic key cause of Parkinson’s disease is reduced production level dopamine by neurons, research studies developed a molecule called LXR (Liver X Receptor) where it has got potential to reduce the loss of dopaminergic neurons. Researchers propose novel ideas to treat Parkinson’s disease to reduce the risk of causing side effects, frequency of dyskinesia, to treat cognitive disorders such as anxiety and depression.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Session on: Clinical Trials in Parkinsons diseases

To develop a promising drug or treatment for Parkinson’s disease observational study is being conducted by scientist in laboratory to provide patients with better life. Clinical trials are performed to slowdown the progression and reduce the symptoms.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, 30th International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on: Parkinson's Psycological disorders

Parkinson's disease is frequently associated with Psychological disorders like psychotic disorders, depression, psychotic disorders, and dementia after examination of psychological disorders in parkinson's disease one-third of Parkinson's patients experience visual hallucinations. Mood disorder and depressive symptoms are common in Parkinson's patients.

Session on: Chememotrapy for Parkinson's Psycological disorders

It is clear that Parkinson's disease is associated with psycological disorders which can be treated with Chemotherapy (drugs) but according to clinical trials drugs for psycological disorders can give side effect on patient so it is vital to know about the theraptic drug used for Parkinson's psycological disorders. Dose reduction of certain anitpakinsoian drugs sometimes improve psychotic disorders, Clozapine is effective and does not worse Parkinsonian symptoms 

To Collaborate Scientific Professionals around the World

Conference Date August 29-31, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner